title: Incidental variants are critical for genomics.
abstract: The topic of incidental variants detected through exome and genome sequencing is controversial, both in clinical practice and in research. The arguments for and against the deliberate analysis and return of incidental variants focus on issues of clinical validity, clinical utility, autonomy, clinical and research infrastructure and costs, and, in the research arena, therapeutic misconception. These topics are briefly reviewed and an argument is made that these variants are the future of genomic medicine. As a field, we should take full advantage of all opportunities to study these variants by searching them out, returning them to patients and research participants, and studying their utility for predictive medicine.
authors: National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA. leslieb@helix.nih.gov
authors: Leslie G
authors: LG
authors: Biesecker
mesh_terms: D030881:Disclosure / Q000941:ethics / Q000639:trends*; D005820:Genetic Testing / Q000379:methods*; D014644:Genetic Variation; D005826:Genetics, Medical / Q000379:methods*; D023281:Genomics / Q000379:methods*; D006801:Humans; D033162:Incidental Findings
references: Genet Med. 2012 Apr;14(4):484-9
references: 22344229
references: J Law Med Ethics. 2008 Summer;36(2):286-91, 212
references: 18547196
references: JAMA. 2006 Jul 12;296(2):212-5
references: 16835427
references: Am J Public Health. 2009 Dec;99(12):2128-34
references: 19833988
references: Pediatrics. 2013 Mar;131(3):564-71
references: 23400601
references: Eur J Hum Genet. 2013 Mar;21(3):248-55
references: 22739341
references: Genet Med. 2012 Apr;14(4):355-7
references: 22481182
references: JAMA. 2006 Dec 20;296(23):2801; author reply 2801-2
references: 17179454
references: J Med Ethics. 2012 Jul;38(7):417-22
references: 22361295
references: Genet Med. 2013 Jul;15(7):565-74
references: 23788249
references: Patient Educ Couns. 2013 Jan;90(1):133-8
references: 23068909
references: J Empir Res Hum Res Ethics. 2010 Sep;5(3):31-41
references: 20831419
references: Genet Med. 2012 Apr;14(4):424-31
references: 22361898
references: Genet Med. 2012 Apr;14(4):473-7
references: 22323070
references: Am J Hum Genet. 2012 Jul 13;91(1):97-108
references: 22703879
references: Genet Med. 2012 Apr;14(4):399-404
references: 22323072
references: Genet Test Mol Biomarkers. 2012 Jan;16(1):21-4
references: 21770772
references: Clin Genet. 2013 Sep;84(3):230-6
references: 23163796
references: Am J Med Genet A. 2012 Oct;158A(10):2519-25
references: 22903777
references: Eur J Hum Genet. 2011 Dec;19(12):1213-7
references: 21731059
references: Circ Cardiovasc Genet. 2010 Dec;3(6):574-80
references: 21156933
references: Genet Med. 2012 Apr;14(4):405-10
references: 22422049
references: Genet Med. 2012 Apr;14(4):358-60
references: 22481183
references: Sci Transl Med. 2011 Jan 12;3(65):65ra4
references: 21228398
references: J Empir Res Hum Res Ethics. 2011 Dec;6(4):53-67
references: 22228060
references: Genet Test Mol Biomarkers. 2012 Mar;16(3):193-7
references: 22047505
references: Am J Bioeth. 2013;13(2):32-42
references: 23391059
references: Genet Med. 2012 Apr;14(4):458-60
references: 22361901
references: Nat Rev Drug Discov. 2012 Feb 01;11(2):89-90
references: 22293554
references: Genet Med. 2012 Apr;14(4):444-50
references: 22361899
references: Nature. 2011 Feb 10;470(7333):204-13
references: 21307933
references: Genet Med. 2013 Jan;15(1):36-44
references: 22995991
references: Genet Test Mol Biomarkers. 2012 Jun;16(6):508-13
references: 22352737
references: Expert Rev Mol Diagn. 2013 Jan;13(1):35-47
references: 23256702
references: Genet Med. 2012 Apr;14(4):461-6
references: 22402758
references: Genet Med. 2013 Jul;15(7):558-64
references: 23370450
references: J Law Med Ethics. 2008 Summer;36(2):249-55, 211
references: 18547192